Literature DB >> 1797309

Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts.

J K Campbell1, R J Marshall, E Winslow.   

Abstract

1. The electrophysiological effects of intravenously administered Org 7797 were compared with those of disopyramide (class Ia), mexiletine (Ib) and propafenone (Ic) in anaesthetized dogs with 5-6 day-old left ventricular myocardial infarcts. 2. Org 7797 (0.5 mg kg-1) slowed conduction at all levels of the myocardium as shown by increases in St-A, AH, HV and QRS intervals, very modestly prolonged atrial and ventricular refractory periods and slightly shortened ventricular repolarization. Sinus node recovery time was increased whilst the RR interval was unchanged. A higher dose (2 mg kg-1) prolonged RR and rendered 5 out of 8 dogs unable to follow an atrial pacing stimulus of mean cycle length 322 ms. 3. Electrophysiological changes induced by propafenone (2 mg kg-1) were qualitatively similar to those of Org 7797 (0.5 mg kg-1). 4. Electrophysiological changes induced by mexiletine (2 mg kg-1) were small or insignificant. The most noticeable effect was a modest increase in the St-A interval and a slight shortening of ventricular repolarization. A higher dose (8 mg kg-1) additionally slowed conduction in the His-Purkinje system and in the ventricular myocardium. 5. Disopyramide (2 and 5 mg kg-1) prolonged all cardiac intervals including JTc, QTc and QT during pacing and prolonged cardiac refractory periods. 6. It was concluded that the electrophysiological profile of Org 7797 is more like that of the Ic agent propafenone than that of the class Ia and Ib drugs, disopyramide and mexiletine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1797309      PMCID: PMC1908530          DOI: 10.1111/j.1476-5381.1991.tb12447.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification.

Authors:  T J Campbell
Journal:  Cardiovasc Res       Date:  1983-06       Impact factor: 10.787

2.  Disopyramide in myocardial infarction.

Authors:  D Ross; J Vohra; J G Sloman
Journal:  Lancet       Date:  1978-02-11       Impact factor: 79.321

3.  Intracardiac electrophysiological study of disopyramide in intact and chemically sympathectomized dogs.

Authors:  C Guimond; C Vasseur; D Godin; B Pelletier; A R LeBlanc; R Nadeau
Journal:  Eur Heart J       Date:  1982-12       Impact factor: 29.983

4.  Mechanism of antifibrillatory action of Org 7797 in regionally ischemic pig heart.

Authors:  M J Janse; F Wilms-Schopman; T Opthof
Journal:  J Cardiovasc Pharmacol       Date:  1990-04       Impact factor: 3.105

5.  Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia.

Authors:  E N Shen; R J Sung; F Morady; A B Schwartz; M M Scheinman; L DiCarlo; W Shapiro
Journal:  J Am Coll Cardiol       Date:  1984-05       Impact factor: 24.094

6.  Anticholinergic effects of disopyramide and quinidine on guinea pig myocardium. Mediation by direct muscarinic receptor blockade.

Authors:  M J Mirro; A S Manalan; J C Bailey; A M Watanabe
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

7.  Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine.

Authors:  H S Karagueuzian; T Katoh; A McCullen; W J Mandel; T Peter
Journal:  Am Heart J       Date:  1984-03       Impact factor: 4.749

8.  Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.

Authors:  J U Doherty; H L Waxman; M G Kienzle; D M Cassidy; F E Marchlinski; A E Buxton; M E Josephson
Journal:  J Am Coll Cardiol       Date:  1984-08       Impact factor: 24.094

9.  Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.

Authors:  S J Connolly; R E Kates; C S Lebsack; D S Echt; J W Mason; R A Winkle
Journal:  Am J Cardiol       Date:  1983-12-01       Impact factor: 2.778

10.  Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias.

Authors:  K Hashimoto; M Ishii; S Komori
Journal:  J Cardiovasc Pharmacol       Date:  1984 Mar-Apr       Impact factor: 3.105

View more
  1 in total

1.  Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.

Authors:  J Leboeuf; M Basiez; R Massingham
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.